By Sriparna Roy April 17 (Reuters) - Eli Lilly's newly launched weight-loss pill was prescribed 1,390 times in the U.S. in ...

The trading gives Waltham-based Kailera a market value of almost $3.1 billion based on the outstanding shares listed in its ...

Guidance from three obesity associations offers recommendations for specific obesity medications and spells out the need to reduce stigma. Will it help?

The Senate Health and Welfare Committee debated a bill that would require Medicaid to cover FDA-approved weight-loss ...

Adolescents who consume more ultra-processed foods (UPFs) have significantly higher odds of being overweight or obese, ...

Louisiana lawmakers debated a bill that would require Medicaid to cover FDA-approved weight-loss medications for its ...

The Greenville metro area ranked among the top 20 cities for 'most overweight and obese cities' by WalletHub. Here's what to ...

"ACC 2026: Ventyx’s VTX3232 Phase IIa results show anti-inflammatory benefits in obesity" was originally created and ...

A new study published in The Journal of Nutrition, a peer-reviewed journal of the American Society for Nutrition, offers new ...

Kailera Therapeutics has filed for an initial public offering (IPO), ​hoping to whet investor appetites with its pipeline of drug candidates for weight loss. Waltham, Massachusetts-based Kailera has ...

Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI to deploy the technology ...

Eli Lilly & Co. said its new weight-loss pill Foundayo was at least as good as an older insulin at warding off heart attacks, ...